A critical advance in cancer investigation is arising with the use of mini-antibodies to reactivate mutated p53. This essential tumor inhibitor protein is frequently disabled in many forms of tumors, leading https://tbookmark.com/story21803734/nanobodies-reactivate-p53-the-new-pathway-for-cancer-therapy